OEM/ODM China N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu
OEM/ODM China N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu Detail:
Manufacturer Supply, High Purity, Commercial Production
Chemical Name: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5
Chemical Name | 2-Chloro-5-Iodobenzoic Acid |
CAS Number | 19094-56-5 |
CAT Number | RF-PI438 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C7H4ClIO2 |
Molecular Weight | 282.46 |
Solubility | Soluble in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White or Pale Yellow Crystals |
Assay / Analysis Method | ≥99.0% (HPLC) |
Melting Point | 161.0~163.0℃ |
Loss on Drying | ≤0.50% |
Residue on Ignition | ≤0.20% |
Total Impurities | ≤1.0% |
Heavy Metals | ≤20ppm |
Residual Solvent | Ethanol |
Test Standard | Enterprise Standard |
Usage | Intermediate of Empagliflozin (CAS: 864070-44-0) |
2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Synthetic Route
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) can be used as a pharmaceutical intermediate in the synthesis of Empagliflozin (CAS: 864070-44-0). Empagliflozin (trade name Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine. On August 1, 2014, the Food and Drug Administration (FDA) officially approved the drug for the treatment of type 2 diabetes, to improve and control blood glucose of adults. Empagliflozin is the third SGLT-2 inhibiting drugs approved by FDA. Another two SGLT-2 inhibitor drugs, Canagliflozin and Dapagliflozin, belonging to Johnson Pharmaceuticals, AstraZeneca and Bristol-Myers Squibb respectively, are approved by FDA in November 2013 and January 2014 respectively.
Product detail pictures:
Related Product Guide:
Our firm has been concentrating on brand strategy. Customers' satisfaction is our best advertising. We also offer OEM provider for OEM/ODM China N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu , The product will supply to all over the world, such as: Cologne, Rwanda, Niger, We adhere to client 1st, top quality 1st, continuous improvement, mutual advantage and win-win principles. When cooperation together with the customer, we provide shoppers with the highest high-quality of service. Established good business relations using the Zimbabwe buyer inside the business, we've got established own brand and reputation. At the identical time, wholeheartedly welcome new and old prospects to our company to go to and negotiate small business.
By Nick from Accra - 2018.09.21 11:01
After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.
By Albert from Belgium - 2017.10.23 10:29